Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity

Pituitary

Volumn 16, Issue 3, 2013, Pages 287-293

  Tritos, Nicholas A ^a,b   Eppakayala, Samatha ^a   Swearingen, Brooke ^a,b   Hedley Whyte, E Tessa ^a,b   Miller, Karen K ^a,b   Nachtigall, Lisa B ^a,b   Grinspoon, Steven K ^a,b   Biller, Beverly M K ^a,b   Klibanski, Anne ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acromegaly; Growth hormone; Hyperthyroidism; Pituitary adenoma; Pituitary apoplexy; Thyrotropin

Indexed keywords

BETA LUTEINIZING HORMONE; BETA THYROTROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE SURGERY; FEMALE; GOITER; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84881374697     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-012-0419-3     Document Type: Article

References (24)

1. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17(6):610-638
2. Beck-Peccoz P, Persani L (2006) TSH-induced hyperthyroidism caused by a pituitary tumor. Nat Clin Pract Endocrinol Metab 2(9):524-528; quiz following p 528
3. Beck-Peccoz P, Persani L (2008) Thyrotropinomas. Endocrinol Metab Clin North Am 37(1):123-134, viii-ix
4. Beck-Peccoz P, Persani L, Mannavola D, Campi I (2009) Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab 23(5):597-606
5. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84(2):476-486
6. Salehi F, Cohen S, Syro LV, Uribe H, Horvath E, Kovacs K, Asa SL (2006) Plurihormonality in pituitary adenomas associated with acromegaly. Endocr Pathol 17(3):291-296
7. Vidal S, Syro L, Horvath E, Uribe H, Kovacs K (1999) Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas. Ultrastruct Pathol 23(3):141-148
8. Luk CT, Kovacs K, Rotondo F, Horvath E, Cusimano M, Booth GL (2012) Plurihormonal pituitary adenoma immunoreactive for TSH, GH, FSH, and PRL. Endocr Pract:1-12 [Epub ahead of print]
9. Black PM, Hsu DW, Klibanski A, Kliman B, Jameson JL, Ridgway EC, Hedley-Whyte ET, Zervas NT (1987) Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 66(2):244-250
10. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74(4):914-919
11. Asa SL (1994) Diseases of the pituitary. Neurosurg Clin N Am 5(1):71-95
12. Lloyd RV, Kovacs K, Young WF Jr, Farrell WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumors. In: DeLellis R, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics: tumors of endocrine organs. IARC Press, Lyon, pp 9-13
13. Ho DM, Hsu CY, Ting LT, Chiang H (2001) Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Histopathology 39(3):310-319
14. Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 28(1):81-117, vi
15. Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148(4):433-442
16. Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, Braverman LE, Oldfield EH, Weintraub BD (1989) Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Int Med 111(10):827-835
17. Beck-Peccoz P, Persani L, Calebiro D, Bonomi M, Mannavola D, Campi I (2006) Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metab 20(4):529-546
18. Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3):348-399
19. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Int Med 120(10):817-820
20. Bills DC, Meyer FB, Laws ER, Jr, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33(4), 602-608; discussion 608-609
21. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51(2):181-188
22. Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD (1987) Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317(1):12-17
23. Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85(4):1487-1491
24. Atkinson JL, Abboud CF, Lane JI (2005) Dramatic volume reduction of a large GH/TSH secreting pituitary tumor with short term Octreotide therapy. Pituitary 8(2):89-91